Adolescents with hemophilia are a patient population with special requirements, having to manage their condition alongside the typical challenges of adolescence. Given the psychosocial impact of hemophilia and a desire to fit in with non-hemophilic peers, they may perceive treatment as more of a burden than a benefit. This can result in low adherence and a high risk of hemophilia-related complications. Hemophilia management has changed over time. To best inform shared decision-making with adolescent patients and their families, healthcare professionals must consider all the currently available evidence, highlighting treatment benefits as appropriate. They should also appreciate the requirements of all adolescents affected by hemophilia, including individuals with non-severe disease and girls/women. We discuss specific issues relating to the management of adolescents with hemophilia: prevention and management of bleeds, treatment adherence, joint health and physical activity, and other health-related issues. A multidisciplinary approach is advocated, and the potential role of digital technology in helping to equip patients with self-management skills to fully engage with treatment is considered. Currently, available hemophilia management generally enables adolescents with hemophilia to lead normal lives, participating in physical activities while maintaining good joint health. However, more work is required to help address both actual and perceived limitations.

Department of Paediatric Haematology Birmingham Children's Hospital Birmingham B4 6NH UK

Department of Paediatric Hematology University Hospital and Masaryk University Brno 601 77 Brno Czech Republic

Goethe University University Hospital Department of Paediatrics and Adolescent Medicine Clinical and Molecular Haemostasis 60590 Frankfurt Germany

Hematology Department Hospital Universitario La Paz IdiPaz Autónoma University 28046 Madrid Spain

See more in PubMed

World Health Organization Adolescent Health. [(accessed on 31 July 2024)]. Available online: https://www.who.int/health-topics/adolescent-health#tab=tab_1.

Sawyer S.M., Azzopardi P.S., Wickremarathne D., Patton G.C. The age of adolescence. Lancet Child. Adolesc. Health. 2018;2:223–228. doi: 10.1016/S2352-4642(18)30022-1. PubMed DOI

Brand B., Dunn S., Kulkarni R. Challenges in the management of haemophilia on transition from adolescence to adulthood. Eur. J. Haematol. 2015;95((Suppl. 81)):30–35. doi: 10.1111/ejh.12582. PubMed DOI

Quon D., Reding M., Guelcher C., Peltier S., Witkop M., Cutter S., Buranahirun C., Molter D., Frey M.J., Forsyth A., et al. Unmet needs in the transition to adulthood: 18- to 30-year-old people with hemophilia. Am. J. Hematol. 2015;90((Suppl. 2)):S17–S22. doi: 10.1002/ajh.24219. PubMed DOI

Young G. From boy to man: Recommendations for the transition process in haemophilia. Haemophilia. 2012;18((Suppl. 5)):27–32. doi: 10.1111/j.1365-2516.2012.02893.x. PubMed DOI

Hoefnagels J.W., Kars M.C., Fischer K., Schutgens R., Schrijvers L.H. The perspectives of adolescents and young adults on adherence to prophylaxis in hemophilia: A qualitative study. Patient Prefer. Adherence. 2020;14:163–171. doi: 10.2147/PPA.S232393. PubMed DOI PMC

Lee Mortensen G., Strand A.M., Almén L. Adherence to prophylactic haemophilic treatment in young patients transitioning to adult care: A qualitative review. Haemophilia. 2018;24:862–872. doi: 10.1111/hae.13621. PubMed DOI

Tagariello G. Use of factor IX concentrates in active teenagers with hemophilia B. Blood Coagul. Fibrinolysis. 2004;15((Suppl. 2)):S9–S10. doi: 10.1097/00001721-200406002-00003. PubMed DOI

Srivastava A., Santagostino E., Dougall A., Kitchen S., Sutherland M., Pipe S.W., Carcao M., Mahlangu J., Ragni M.V., Windyga J., et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26:1–158. doi: 10.1111/hae.14046. PubMed DOI

Okaygoun D., Oliveira D.D., Soman S., Williams R. Advances in the management of haemophilia: Emerging treatments and their mechanisms. J. Biomed. Sci. 2021;28:64. doi: 10.1186/s12929-021-00760-4. PubMed DOI PMC

Urasiński T., Paczóska K., Badowska W., Bobrowska H., Dakowicz Ł., Dobaczewski G., Latos-Grażyńska E., Karolczyk G., Klukowska A., Kołtan A., et al. Real pandemic world results of pharmacokinetic-tailored personalized prophylaxis of bleeds in Polish children and adolescents with severe hemophilia A. Front. Pediatr. 2023;11:1084539. doi: 10.3389/fped.2023.1084539. PubMed DOI PMC

Weyand A.C., Malec L., Pipe S.W. Advancements in haemophilia A and health equity: Is it time to redefine severity? Lancet Haematol. 2024;11:e90–e92. doi: 10.1016/S2352-3026(23)00270-3. PubMed DOI

van Galen K., Lavin M., Skouw-Rasmussen N., Fischer K., Noone D., Pollard D., Mauser-Bunschoten E., Khair K., Gomez K., van Loon E., et al. European principles of care for women and girls with inherited bleeding disorders. Haemophilia. 2021;27:837–847. doi: 10.1111/hae.14379. PubMed DOI

Weyand A.C., Sidonio R.F., Jr., Sholzberg M. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues. Haemophilia. 2022;28((Suppl. 4)):18–25. doi: 10.1111/hae.14535. PubMed DOI PMC

Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. J. Blood Med. 2014;5:207–218. doi: 10.2147/JBM.S50644. PubMed DOI PMC

Aronstam A., Rainsford S.G., Painter M.J. Patterns of bleeding in adolescents with severe haemophilia A. Br. Med. J. 1979;1:469–470. doi: 10.1136/bmj.1.6161.469. PubMed DOI PMC

Richter D., Heller C., Heuer M., Stein M., Schultze-Strasser S., Schwabe D., Königs C. Care, needs and perceptions of adolescents and young adults growing up with hemophilia A or B; Proceedings of the Annual Meeting of the Society of Thrombosis and Hemostasis (GTH); Basel, Switzerland. 16 February 2017.

Blanchette V.S., Key N.S., Ljung L.R., Manco-Johnson M.J., van den Berg H.M., Srivastava A. Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee. Definitions in hemophilia: Communication from the SSC of the ISTH. J. Thromb. Haemost. 2014;12:1935–1939. doi: 10.1111/jth.12672. PubMed DOI

Auerswald G., Dolan G., Duffy A., Hermans C., Jimenez-Yuste V., Ljung R., Morfini M., Lambert T., Salek S.Z. Pain and pain management in haemophilia. Blood Coagul. Fibrinolysis. 2016;27:845–854. doi: 10.1097/MBC.0000000000000571. PubMed DOI PMC

de Moerloose P., Davis J.A., Benchikh El Fegoun S., Habis R., Klamroth R. Barriers and challenges for the fast treatment of bleeds in the non-haemophilia treatment centre hospital setting. Haemophilia. 2020;26:422–430. doi: 10.1111/hae.13956. PubMed DOI

Khair K., Pelentsov L. Assessing the supportive care needs of parents with a child with a bleeding disorder using the Parental Needs Scale for Rare Diseases (PNS-RD): A single-centre pilot study. Haemophilia. 2019;25:831–837. doi: 10.1111/hae.13826. PubMed DOI

Khair K., Meerabeau L., Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18:1105–1113. doi: 10.1111/hex.12083. PubMed DOI PMC

Schrijvers L.H., Schuurmans M.J., Fischer K. Promoting self-management and adherence during prophylaxis: Evidence-based recommendations for haemophilia professionals. Haemophilia. 2016;22:499–506. doi: 10.1111/hae.12904. PubMed DOI

World Health Organization Adherence to Long-Term Therapies: Evidence for Action. 2003. [(accessed on 31 July 2024)]. Available online: https://iris.who.int/handle/10665/42682.

Geraghty S., Dunkley T., Harrington C., Lindvall K., Maahs J., Sek J. Practice patterns in haemophilia A therapy—Global progress towards optimal care. Haemophilia. 2006;12:75–81. doi: 10.1111/j.1365-2516.2006.01189.x. PubMed DOI

McLaughlin J.M., Witkop M.L., Lambing A., Anderson T.L., Munn J., Tortella B. Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia. Haemophilia. 2014;20:506–512. doi: 10.1111/hae.12360. PubMed DOI

Petrini P., Seuser A. Haemophilia care in adolescents—Compliance and lifestyle issues. Haemophilia. 2009;15:15–19. doi: 10.1111/j.1365-2516.2008.01948.x. PubMed DOI

Russo K. Assessment and treatment of adolescents with chronic medical conditions. J. Health Serv. Psychol. 2022;48:69–78. doi: 10.1007/s42843-022-00059-4. PubMed DOI PMC

Richards M., Altisent C., Batorova A., Chambost H., Dolan G., de Moerloose P., Fraga M., Hermans C., Karafoulidou A., Klamroth R., et al. Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia. 2007;13:473–479. doi: 10.1111/j.1365-2516.2007.01478.x. PubMed DOI

Berntorp E., Hermans C., Solms A., Poulsen L., Mancuso M.E. Optimising prophylaxis in haemophilia A: The ups and downs of treatment. Blood Rev. 2021;50:100852. doi: 10.1016/j.blre.2021.100852. PubMed DOI

Hermans C., Pierce G.F. Ultra-Long factor VIII: A major step forward toward a hemophilia-free mind. J. Thromb. Haemost. 2024;22:1844–1846. doi: 10.1016/j.jtha.2024.04.010. PubMed DOI

Mancuso M.E., Croteau S.E., Klamroth R. Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies. Haemophilia. 2024;30((Suppl. 3)):39–44. doi: 10.1111/hae.14976. PubMed DOI

Álvarez-Román M.T., Shapiro A.D., Ragni M.V., Palmborg H., Bystrická L., Szamosi J., Casiano S., Chambost H. Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand. Res. Pract. Thromb. Haemost. 2023;7:102163. doi: 10.1016/j.rpth.2023.102163. PubMed DOI PMC

Manco-Johnson M.J., Soucie J.M., Gill J.C. Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: A surveillance project. Blood. 2017;129:2368–2374. doi: 10.1182/blood-2016-02-683169. PubMed DOI PMC

Oldenburg J., Zimmermann R., Katsarou O., Theodossiades G., Zanon E., Niemann B., Kellermann E., Lundin B. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand. Haemophilia. 2015;21:171–179. doi: 10.1111/hae.12539. PubMed DOI PMC

Rodriguez-Merchan E.C., Jimenez-Yuste V., Aznar J.A., Hedner U., Knobe K., Lee C.A., Ljung R., Querol F., Santagostino E., Valentino L.A., et al. Joint protection in haemophilia. Haemophilia. 2011;17((Suppl. 2)):1–23. doi: 10.1111/j.1365-2516.2011.02615.x. PubMed DOI

Mancuso M.E., Holstein K., O’Donnell J.S., Lobet S., Klamroth R. Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia. 2023;29:619–628. doi: 10.1111/hae.14734. PubMed DOI

Fromme A., Dreeskamp K., Pollmann H., Thorwesten L., Mooren F.C., Völker K. Participation in sports and physical activity of haemophilia patients. Haemophilia. 2007;13:323–327. doi: 10.1111/j.1365-2516.2007.01456.x. PubMed DOI

Schmidt D.E., Michalopoulou A., Fischer K., Motwani J., Andersson N.G., Pergantou H., Ranta S., PedNet Study G. Long-term joint outcomes in adolescents with moderate or severe haemophilia A. Haemophilia. 2022;28:1054–1061. doi: 10.1111/hae.14636. PubMed DOI PMC

Versloot O., Timmer M.A., de Kleijn P., Schuuring M., van Koppenhagen C.F., van der Net J., Fischer K. Sports participation and sports injuries in Dutch boys with haemophilia. Scand. J. Med. Sci. Sports. 2020;30:1256–1264. doi: 10.1111/sms.13666. PubMed DOI PMC

Kennedy M., O’Gorman P., Monaghan A., Lavin M., O’Mahony B., O’Connell N.M., O’ Donnell J.S., Turecek P.L., Gormley J., on behalf of the Irish Personalised Approach to the Treatment of Haemophilia (iPATH) study group A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen. Haemophilia. 2021;27:544–562. doi: 10.1111/hae.14282. PubMed DOI PMC

Wang M., Álvarez-Román M.T., Chowdary P., Quon D.V., Schafer K. Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: A literature review and case reports. Blood Coagul. Fibrinolysis. 2016;27:737–744. doi: 10.1097/MBC.0000000000000565. PubMed DOI PMC

Moretti L., Bizzoca D., Buono C., Ladogana T., Albano F., Moretti B. Sports and children with hemophilia: Current trends. Children. 2021;8:1064. doi: 10.3390/children8111064. PubMed DOI PMC

Schoenmakers M.A., Gulmans V.A., Helders P.J., van den Berg H.M. Motor performance and disability in Dutch children with haemophilia: A comparison with their healthy peers. Haemophilia. 2001;7:293–298. doi: 10.1046/j.1365-2516.2001.00504.x. PubMed DOI

Harris S., Boggio L.N. Exercise may decrease further destruction in the adult haemophilic joint. Haemophilia. 2006;12:237–240. doi: 10.1111/j.1365-2516.2006.01214.x. PubMed DOI

Tiktinsky R., Falk B., Heim M., Martinovitz U. The effect of resistance training on the frequency of bleeding in haemophilia patients: A pilot study. Haemophilia. 2002;8:22–27. doi: 10.1046/j.1365-2516.2002.00575.x. PubMed DOI

National Bleeding Disorders Foundation Steps for Living. [(accessed on 31 July 2024)]. Available online: https://stepsforliving.hemophilia.org/

Ai D., Huang K., Li G., Zhen Y., Wu X., Zhang N., Huo A., Chen Z., Wu R. Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A. Front. Pediatr. 2022;10:1045070. doi: 10.3389/fped.2022.1045070. PubMed DOI PMC

Tomschi F., Hmida J., Herzig S., Ransmann P., Brühl M., Schmidt A., Herzig M., Goldmann G., Strauß A.C., Oldenburg J., et al. Physical activity and factor VIII levels in patients with haemophilia: A real-world prospective observational study. Haemophilia. 2024;30:419–425. doi: 10.1111/hae.14965. PubMed DOI

Chang C.Y., Li T.Y., Cheng S.N., Pan R.Y., Cheng C.N., Wang H.J., Hu S.H., Chen Y.C. Obesity and overweight in patients with hemophilia: Prevalence by age, clinical correlates, and impact on joint bleeding. J. Chin. Med. Assoc. 2019;82:289–294. doi: 10.1097/JCMA.0000000000000047. PubMed DOI

Olivieri M., Königs C., Heller C., Horneff S., Oldenburg J., Halimeh S., Kentouche K., Knöfler R., Fischer L., Pfrepper C., et al. Prevalence of Obesity in young patients with severe haemophilia and its potential impact on factor VIII consumption in Germany. Hamostaseologie. 2019;39:355–359. doi: 10.1055/s-0039-1677874. PubMed DOI

El-Atoum B., Prather G., Arden D., Thompson S., Jubelirer S., Badawi M., Meyer A. Association between weight status and joint function in adult and pediatric patients with hemophilia. Haemophilia. 2022;28:e101–e104. doi: 10.1111/hae.14541. PubMed DOI

Limperg P.F., Haverman L., Maurice-Stam H., Coppens M., Valk C., Kruip M., Eikenboom J., Peters M., Grootenhuis M.A. Health-related quality of life, developmental milestones, and self-esteem in young adults with bleeding disorders. Qual. Life Res. 2018;27:159–171. doi: 10.1007/s11136-017-1696-0. PubMed DOI PMC

Azeredo-da-Silva A.F., Zanotto B.S., Kuwabara Y.S., Mata V.E. Quality of life in children and adolescents with hemophilia A: A systematic review and meta-analysis. Res. Pract. Thromb. Haemost. 2023;7:100008. doi: 10.1016/j.rpth.2022.100008. PubMed DOI PMC

Breakey V.R., Blanchette V.S., Bolton-Maggs P.H. Towards comprehensive care in transition for young people with haemophilia. Haemophilia. 2010;16:848–857. doi: 10.1111/j.1365-2516.2010.02249.x. PubMed DOI

Parish K.L. Sexuality and haemophilia: Connections across the life-span. Haemophilia. 2002;8:353–359. doi: 10.1046/j.1365-2516.2002.00647.x. PubMed DOI

Blamey G., Buranahirun C., Buzzi A., Cooper D.L., Cutter S., Geraghty S., Saad H., Yang R. Hemophilia and sexual health: Results from the HERO and B-HERO-S studies. Patient Relat. Outcome Meas. 2019;10:243–255. doi: 10.2147/PROM.S211339. PubMed DOI PMC

Banchev A. Sexual activity and the adolescent with haemophilia. Acta Biomed. 2023;94:e2023003. doi: 10.23750/abm.v94i2.14168. PubMed DOI PMC

Aydin Köker S., Kaygusuz A., Oymak Y., Karapϊnar T.H., Çubukçu D., Gözmen S., Ay Y., Vergϊn R.C. Assessment of self-image with the offer self-image questionnaire in adolescents with hemophilia: A single-center experience. J. Pediatr. Hematol. Oncol. 2020;42:e159–e163. doi: 10.1097/MPH.0000000000001664. PubMed DOI

Gray W.N., Schaefer M.R., Resmini-Rawlinson A., Wagoner S.T. Barriers to transition from pediatric to adult care: A systematic review. J. Pediatr. Psychol. 2018;43:488–502. doi: 10.1093/jpepsy/jsx142. PubMed DOI

Bidlingmaier C., Olivieri M., Schilling F.H., Kurnik K., Pekrul I. Health care transition of adolescents and young adults with haemophilia: The situation in Germany and the Munich experience. Hamostaseologie. 2020;40:97–104. doi: 10.1055/s-0039-3402804. PubMed DOI

The Haemophilia Society Career Choices. [(accessed on 31 July 2024)]. Available online: https://haemophilia.org.uk/support/day-day-living/other-information-sources/career-choices/#:~:text=Choosing%20a%20career&text=Our%20members%20have%20various%20roles,%2C%20catering%2C%20farming%20and%20engineering.

O’Connell D. Career Decisions for Teens with Bleeding Disorders. [(accessed on 31 July 2024)]. Available online: https://hemaware.org/life/career-decisions-teens-bleeding-disorders.

St-Louis J., Chowdary P., Dolan G., Goodyear D., Strike K., Pollard D., Teitel J. Multidisciplinary team care of patients with hemophilic arthropathy: A qualitative assessment of contemporary practice in the UK and Canada: Canada/UK: MDT practices for hemophilia. Clin. Appl. Thromb. Hemost. 2022;28:10760296211070002. doi: 10.1177/10760296211070002. PubMed DOI PMC

van Os S., Ryder N., Hart D.P., Troop N. Adherence to prophylaxis in adolescents and young adults with severe haemophilia: A qualitative study with healthcare professionals. Health Psychol. Behavi Med. 2020;8:55–72. doi: 10.1080/21642850.2020.1718501. PubMed DOI PMC

Low J.K., Manias E. Use of technology-based tools to support adolescents and young adults with chronic disease: Systematic review and meta-analysis. JMIR Mhealth Uhealth. 2019;7:e12042. doi: 10.2196/12042. PubMed DOI PMC

Zapotocka E., Batorova A., Bilic E., Boban A., Escuriola Ettingshausen C., Faganel Kotnik B., Hrdlickova R., Laguna P., Machal J., Nemes L., et al. First experience of a hemophilia monitoring platform: Florio HAEMO. Res. Pract. Thromb. Haemost. 2022;6:e12685. doi: 10.1002/rth2.12685. PubMed DOI PMC

Iorio A., Keepanasseril A., Foster G., Navarro-Ruan T., McEneny-King A., Edginton A.N., Thabane L. Development of a Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Study protocol. JMIR Res. Protoc. 2016;5:e239. doi: 10.2196/resprot.6558. PubMed DOI PMC

Khair K., Holland M., Carrington S. Social networking for adolescents with severe haemophilia. Haemophilia. 2012;18:e290–e296. doi: 10.1111/j.1365-2516.2011.02689.x. PubMed DOI

Kerekes N., Bador K., Sfendla A., Belaatar M., Mzadi A.E., Jovic V., Damjanovic R., Erlandsson M., Nguyen H.T.M., Nguyen N.T.A., et al. Changes in adolescents’ psychosocial functioning and well-being as a consequence of long-term COVID-19 restrictions. Int. J. Environ. Res. Public. Health. 2021;18:8755. doi: 10.3390/ijerph18168755. PubMed DOI PMC

Pop L.M., Iorga M., Iurcov R. Body-esteem, self-esteem and loneliness among social media young users. Int. J. Environ. Res. Public. Health. 2022;19:5064. doi: 10.3390/ijerph19095064. PubMed DOI PMC